Avivomed Inc.

SEC filing

Biotechnology · Roseville, MN

Form D on EDGAR

Amount raised$5Msold at filing

Total offering$12M$7M still open

Investors in the raise7count reported to the SEC

FiledApr 21, 2026first sale Apr 16, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Paul MazanecExecutive Officer, Director

Theresa C. PappasDirector

Ketan K. PatelDirector

Casper C. de ClercqDirector

Douglas C. ReedDirector

Mudit K. JainDirector

Executive officers, directors and promoters as listed on the Form D.